HCAT
NASDAQHealth Catalyst Inc
News · 26 weeks47-100%
2025-10-262026-04-19
Mix2390d
- Insider11(48%)
- SEC Filings5(22%)
- Other3(13%)
- Earnings2(9%)
- Leadership1(4%)
- Analyst1(4%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Health Catalyst IncSCHEDULE 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
- ANALYSTHealth Catalyst downgraded by Wells Fargo with a new price targetWells Fargo downgraded Health Catalyst from Overweight to Equal Weight and set a new price target of $1.00
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Health Catalyst IncSCHEDULE 13D/A - Health Catalyst, Inc. (0001636422) (Subject)
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 70,455 shares, decreasing direct ownership by 5% to 1,457,978 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECSEC Form S-8 filed by Health Catalyst IncS-8 - Health Catalyst, Inc. (0001636422) (Filer)
- SECSEC Form 10-K filed by Health Catalyst Inc10-K - Health Catalyst, Inc. (0001636422) (Filer)
- SECHealth Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Reports Fourth Quarter and Year End 2025 ResultsSALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025. "We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million," said Ben Albert, CEO of Health Catalyst "In 2026, we are focused on the future and on positioning Health Catalyst for long‑term success. As I continue to assess the business, I see both meaningful opportunities and clear areas where we must improve. I am confident in the
- INSIDERGeneral Counsel Landry Benjamin covered exercise/tax liability with 20,838 shares, decreasing direct ownership by 5% to 378,318 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief Financial Officer Alger Jason covered exercise/tax liability with 26,970 shares, decreasing direct ownership by 4% to 741,644 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 4,966 shares, decreasing direct ownership by 0.32% to 1,528,433 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERDirector Larson-Green Julie was granted 8,361 shares, increasing direct ownership by 11% to 81,934 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief People Officer Llewelyn Linda covered exercise/tax liability with 13,836 shares, decreasing direct ownership by 4% to 329,651 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- PRHealth Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and year end 2025 operating results on Thursday, March 12, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ425." A live audio webcast will be available online at https://ir.healthc
- INSIDERCEO Albert Benjamin was granted 968,833 shares and covered exercise/tax liability with 13,304 shares, increasing direct ownership by 165% to 1,533,399 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief Financial Officer Alger Jason was granted 529,722 shares and covered exercise/tax liability with 7,522 shares, increasing direct ownership by 212% to 768,614 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERGeneral Counsel Landry Benjamin was granted 305,473 shares and covered exercise/tax liability with 6,317 shares, increasing direct ownership by 299% to 399,156 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief People Officer Llewelyn Linda was granted 204,695 shares and covered exercise/tax liability with 4,471 shares, increasing direct ownership by 140% to 343,487 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECSEC Form 144 filed by Health Catalyst Inc144 - Health Catalyst, Inc. (0001636422) (Subject)
- INSIDERDirector Gallagher Duncan was granted 7,562 shares, increasing direct ownership by 6% to 132,023 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Health Catalyst IncSCHEDULE 13D/A - Health Catalyst, Inc. (0001636422) (Subject)
- SECHealth Catalyst Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Appoints Ben Albert as Chief Executive OfficerAlbert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc. (NASDAQ:HCAT) ("Health Catalyst" or the "Company"), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert, the Company's President and Chief Operating Officer (COO), was appointed to serve as Chief Executive Officer (CEO) and as a member of Health Catalyst's Board of Directors ( "Board"), effective February 12, 2026.
- SECHealth Catalyst Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- SECSEC Form SCHEDULE 13D filed by Health Catalyst IncSCHEDULE 13D - Health Catalyst, Inc. (0001636422) (Subject)